Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 10/2001

01-12-2001

Multivitamin use and colon cancer mortality in the Cancer Prevention Study II cohort (United States)

Authors: Eric J. Jacobs, Cari J. Connell, Alpa V. Patel, Ann Chao, Carmen Rodriguez, Jennifer Seymour, Marjorie L. McCullough, Eugenia E. Calle, Michael J. Thun

Published in: Cancer Causes & Control | Issue 10/2001

Login to get access
Metadata
Title
Multivitamin use and colon cancer mortality in the Cancer Prevention Study II cohort (United States)
Authors
Eric J. Jacobs
Cari J. Connell
Alpa V. Patel
Ann Chao
Carmen Rodriguez
Jennifer Seymour
Marjorie L. McCullough
Eugenia E. Calle
Michael J. Thun
Publication date
01-12-2001
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 10/2001
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1013716323466

Other articles of this Issue 10/2001

Cancer Causes & Control 10/2001 Go to the issue

OriginalPaper

Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case–control study in Italy

OriginalPaper

Family cancer history and risk of childhood acute leukemia (France)

OriginalPaper

Alcohol consumption increases the risk of fatal breast cancer (United States)

Note

Tobacco Note

Authors Index

Author index to Volume 12

OriginalPaper

Metabolic disorders and breast cancer risk (United States)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits